Teva and Novartis settle in US over generic Famvir after "at risk" launch
18 February 2010
Nancy Faigen
Teva Pharmaceutical Industries and
Novartis have agreed to settle long-standing patent infringement litigation relating to Teva's US generic version of the genital herpes drug Famvir (famciclovir), including all claims for patent infringement and damages.
The agreement releases Teva from all...
Please Login to read the full article.
18 February 2010
Nancy Faigen
The agreement releases Teva from all...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Watson beats Cephalon's cheeky, fizzy fentanyl patents
- Watson beatsTeva on appeals overgeneric Seasonique: sued by Novartis over Exelon
- Mylan loses bid to have US Teva patent infringement suit on Copaxone tossed out
- Sandoz wants Novo's sole US Prandin patent ruled invalid in a long running case
COMMENT
Other Informa Comment
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
